Tanaka, Y., Takeuchi, T., Yamanaka, H., Nanki, T., Umehara, H., Yasuda, N., . . . Imai, T. (2021). Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study. Arthritis Rheumatol.
Chicago-stil citatTanaka, Yoshiya, et al. "Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study." Arthritis Rheumatol 2021.
MLA-referensTanaka, Yoshiya, et al. "Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study." Arthritis Rheumatol 2021.